CLDI

Allan Camaisa

Known title: CEO and Chairman of the BoardCIK: 0001990674

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 7, 2026

CLDI Included in After-Market Movers List. Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.

this person other insiders at CLDI

Transaction History

CLDI▼ Sell$1K
CLDI▼ Sell$16K
CLDI▲ Buy$81K

We use analytics to understand how market-wall is used. No personal data is sold.